Evidence map›Paper›PMID 38735925›Full record

ArticleClinical proteomics2024

Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics.

Sudipa Maity, Yuanyu Huang, Mitchell D Kilgore, Abbigail N Thurmon, Lee O Vaasjo, Maria J Galazo, Xiaojiang Xu, Jing Cao, Xiaoying Wang, Bo Ning and 2 more

Abstract read
In one paragraph

Article in Clinical proteomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sudipa MaityCenter for Cellular and Molecular Diagnostics, Tulane University School of Medicine, New Orleans, LA, USA.
Yuanyu HuangCenter for Cellular and Molecular Diagnostics, Tulane University School of Medicine, New Orleans, LA, USA.
Mitchell D KilgoreClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, USA.
Abbigail N ThurmonDepartment of Cell and Molecular Biology, Tulane University, New Orleans, LA, USA.
Lee O VaasjoTulane Brain Institute, New Orleans, LA, USA.
Maria J GalazoDepartment of Cell and Molecular Biology, Tulane University, New Orleans, LA, USA.
Xiaojiang XuDepartment of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Jing CaoDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xiaoying WangClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, USA.
Bo NingCenter for Cellular and Molecular Diagnostics, Tulane University School of Medicine, New Orleans, LA, USA.
Ning LiuClinical Neuroscience Research Center, Department of Neurosurgery and Neurology, Tulane University School of Medicine, New Orleans, LA, USA. nliu3@tulane.edu.
Jia FanCenter for Cellular and Molecular Diagnostics, Tulane University School of Medicine, New Orleans, LA, USA. jfan5@tulane.edu.

Funding

Tulane COBRE in Cardiometabolic Diseases Clinical Research CoreP20GM109036 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI Katherine Teresa Mills · 2016 to 2026
$25.3M
Role of Irg-1/itaconate in modulating secondary brain damage after traumatic brain injury in miceR01NS126503 · NINDS · TULANE UNIVERSITY OF LOUISIANA · PI XIAOYING WANG · 2023 to 2026
$1.7M
Acquisition of next-generation Orbitrap Eclipse Tribrid Mass Spectrometer systemS10OD032453 · OD · TULANE UNIVERSITY OF LOUISIANA · PI FAN, JIA · 2022 to 2022
$1.4M
Quantification of brain-derived extracellular vesicle microRNAs in blood by a liposome-mediated CRISPR assay for traumatic brain injury detectionR21NS130542 · NINDS · TULANE UNIVERSITY OF LOUISIANA · PI HU, TONY Y. · 2022 to 2022
$437k
American Heart Association Career Development Award 23CDA1055341National Institutes of Health, USA P20GM109036National Institutes of Health, USA R01NS126503-01A1National Institutes of Health, USA R21AI169583National Institutes of Health, USA R21NS130542NIGMS NIH HHS P20 GM109036NIH HHS S10 OD032453NINDS NIH HHS R01 NS126503NINDS NIH HHS R21 NS130542Tulane Brain Institute microscopy core funded by a Louisiana Board of Regents Enhancement Grant LEQSF(2018-23)-ENH-DE-15
6 · The paper itself

Abstract

backgroundTraumatic brain injury (TBI) often results in diverse molecular responses, challenging traditional proteomic studies that measure average changes at tissue levels and fail to capture the complexity and heterogeneity of the affected tissues. Spatial proteomics offers a solution by providing insights into sub-region-specific alterations within tissues. This study focuses on the hippocampal sub-regions, analyzing proteomic expression profiles in mice at the acute (1 day) and subacute (7 days) phases of post-TBI to understand subregion-specific vulnerabilities and long-term consequences.

methodsThree mice brains were collected from each group, including Sham, 1-day post-TBI and 7-day post-TBI. Hippocampal subregions were extracted using Laser Microdissection (LMD) and subsequently analyzed by label-free quantitative proteomics.

resultsThe spatial analysis reveals region-specific protein abundance changes, highlighting the elevation of FN1, LGALS3BP, HP, and MUG-1 in the stratum moleculare (SM), suggesting potential immune cell enrichment post-TBI. Notably, established markers of chronic traumatic encephalopathy, IGHM and B2M, exhibit specific upregulation in the dentate gyrus bottom (DG2) independent of direct mechanical injury. Metabolic pathway analysis identifies disturbances in glucose and lipid metabolism, coupled with activated cholesterol synthesis pathways enriched in SM at 7-Day post-TBI and subsequently in deeper DG1 and DG2 suggesting a role in neurogenesis and the onset of recovery. Coordinated activation of neuroglia and microtubule dynamics in DG2 suggest recovery mechanisms in less affected regions. Cluster analysis revealed spatial variations post-TBI, indicative of dysregulated neuronal plasticity and neurogenesis and further predisposition to neurological disorders. TBI-induced protein upregulation (MUG-1, PZP, GFAP, TJP, STAT-1, and CD44) across hippocampal sub-regions indicates shared molecular responses and links to neurological disorders. Spatial variations were demonstrated by proteins dysregulated in both or either of the time-points exclusively in each subregion (ELAVL2, CLIC1 in PL, CD44 and MUG-1 in SM, and SHOC2, LGALS3 in DG).

conclusionsUtilizing advanced spatial proteomics techniques, the study unveils the dynamic molecular responses in distinct hippocampal subregions post-TBI. It uncovers region-specific vulnerabilities and dysregulated neuronal processes, and potential recovery-related pathways that contribute to our understanding of TBI's neurological consequences and provides valuable insights for biomarker discovery and therapeutic targets.

Indexed as

Acute and sub-acute phaseHippocampusLaser microdissection (LMD)Liquid chromatography–mass spectrometrySpatial proteomicsTraumatic brain injury

Identifiers

PMID38735925
PMCPMC11089002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.